News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

ICR researchers in Chelsea lab
ICR research ranks in top five globally for academic influence, collaboration and commercial impact

24/08/20

The Institute of Cancer Research has again ranked among the top higher education institutions in the world for the impact of our research academically and commercially.
Breast cancer cell
Scientists discover three new genetic variants linked to male breast cancer

12/08/20

UK scientists have discovered three new genetic changes that increase the risk of breast cancer in men, in the world’s largest genetic study of the causes of male breast cancer to date.
A nurse using ultrasound to image a region of a patient's body
Computer-assisted ultrasound imaging could help deliver more accurate radiotherapy for prostate cancer

27/07/20

A computer algorithm which helps radiographers interpret ultrasound images could improve radiotherapy treatment for patients with prostate cancer, a new study suggests.
Breast Cancer Cells Credit Min Yu 547x410
Immune system could be trained to spot drug-resistant cancers

23/07/20

Aggressive cancers could be treated with immunotherapies that direct the immune system to kill cancer cells with specific drug resistance-causing mutations, a major new study suggests.
ICR Logo
Study strengthens calls to clear cancer diagnosis backlog

20/07/20

Delays to cancer referral through reduced use of the urgent GP referral pathway during the coronavirus pandemic could result in more than a thousand additional deaths in England, a new study reports.
ICR Logo
Long-term safety of radiotherapy in fewer doses for patients with early breast cancer demonstrated in 10-year study

14/07/20

A lower total dose of radiotherapy delivered in fewer but larger doses is as safe in the long term as breast cancer radiotherapy courses giving multiple small doses, according to the final results of a 10-year study.
ICR_547_410_hres
Urgent call to kick-start life-saving cancer research so cancer patients don’t get left behind

14/07/20

Scientists researching new treatments for cancer patients are calling for urgent support to ensure the disruption caused by the coronavirus crisis does not damage long-term progress to defeat the disease.
ICR Logo
Researchers reveal discovery of new cancer drug fadraciclib

13/07/20

Scientists have revealed details of the discovery of a new cancer drug that could be used to treat a range of cancer types, including some blood cancers and solid tumours.
Lung cancer cells
Lung cancer in non-smokers likely to respond differently to treatment

09/07/20

Lung cancer in non-smokers is a biologically distinct disease from that in smokers, according to a new study. Researchers also found it has characteristics that mean it could be targeted with tailored treatments.
Johann de Bono and Mateus Crespo Prostate cancer cells 547x410
‘Reprogramming’ immune cells could switch defence into attack to treat prostate cancer

02/07/20

Drugs that can ‘reprogramme’ immune cells from protecting cancer to attacking it could be an effective new treatment for some men with advanced prostate cancer, a new study shows.
Virtual Terry Fox Run launches in the UK in aid of the ICR

01/07/20

A virtual run has been launched in the UK inspired by a prominent Canadian cancer research activist, to raise money for the Institute of Cancer Research, London.
ICR Logo
Scientists expand understanding of how DNA is organised

01/07/20

Scientists at The Institute of Cancer Research have uncovered new information about vital structures inside cells which are responsible for organising our DNA.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.